• Explore /
  • Poster
  • / Osimertinib in non-small cell lung cancer (NSCLC) with atypical EGFR activating mutations: A retrospective multicenter study.

Osimertinib in non-small cell lung cancer (NSCLC) with atypical EGFR activating mutations: A retrospective multicenter study.

Abstract Video & Slides Poster

Authors

null

Jingran Ji

University of California Davis Comprehensive Cancer Center, Sacramento, CA

Jingran Ji , Jacqueline V Aredo , Andrew Piper-Vallillo , Laura Huppert , Julia K Rotow , Hatim Husain , Susan L Stewart , Rosemary Cobb , Heather A. Wakelee , Collin Michael Blakely , Melisa L. Wong , Matthew A. Gubens , Justin Chen , Geoffrey R. Oxnard , Caroline Elizabeth McCoach , Zofia Piotrowska , Joel W. Neal , Jonathan W. Riess

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 38: 2020 (suppl; abstr 9570)

DOI

10.1200/JCO.2020.38.15_suppl.9570

Abstract #

9570

Poster Bd #

336

Abstract Disclosures

Similar Posters

First Author: Xin Zhao

First Author: Jonathan N. Priantti

First Author: Jan Alexander Stratmann

First Author: Satoru Miura